Reglitazar

Reglitazar Uses, Dosage, Side Effects, Food Interaction and all others data.

Reglitazar, an isoxazolidine-3,5-dione derivative, is being developed by Pfizer for the treatment of diabetes. It is the first non-thiazolidenedione to enter clinical trials.

Reglixane shows a hypoglycemic effect and also a stronger triglyceride-lowering effect than the thiazolidine-2,4-diones. In preclinical studies, reglixane has been shown to prevent several diabetic complications, such as cataract, nephropathy, and neuropathy.

Table Of contents

• Reglitazar
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Reglitazar
Generic	Reglitazar
Reglitazar Other Names	Reglitazar, Reglixane
Type
Formula	C22H20N2O5
Weight	Average: 392.411 Monoisotopic: 392.137221752
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

For the treatment of diabetes mellitus type 1 and 2.

How Reglitazar works

Reglixane is an agonist of peroxisome proliferator-activated receptor (PPAR) gamma and alpha.

Innovators Monograph

You find simplified version here Reglitazar